Investor & Analyst Breakfast, hosted by BioLineRx (BLRX)

The event will feature presentations by KOLs Ezra Cohen, MD, FRCPSC, FASCO (UC San Diego) and Manuel Hidalgo, MD, PhD (BIDMS, Harvard Medical School), who will discuss the progress made in the clinical development of immunotherapies beyond checkpoint inhibitors and the unmet medical need in treating patients with pancreatic cancer.